ArticleBMC infectious diseases2026
Comparison of severe and general Mycoplasma pneumoniae pneumonia in children: a targeted next-generation sequencing based study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence and severity of Mycoplasma pneumoniae pneumonia (MPP) in children have increased after the pandemic of COVID-19, raising public concern. However, factors that affect the severity of MPP have not been well described. This study aimed to investigate the influence of Mycoplasma pneumoniae characters, respiratory co-existing pathogens, and host response on the severity of MPP.
methodsClinical characteristics of 288 children hospitalized for MPP between November 2023 and July 2024 were analyzed retrospectively. Patients were divided into severe MPP (SMPP) and general MPP (GMPP) groups according to disease severity. Targeted next-generation sequencing (tNGS) was employed to analyze the respiratory pathogens of patients.
resultsOf 288 cases, there were 113 SMPP and 175 GMPP. Compared with GMPP group, children with SMPP had significantly higher levels of neutrophil percentage, Neutrophil to Lymphocyte Ratio (NLR), C-Reactive Protein (CRP), Alanine aminotransferase (ALT), Lactic dehydrogenase (LDH) and D-D dimer (all P < 0.05), which reflected a higher host immune response in SMPP group. Meanwhile, tNGS based pathogen analysis showed that Mycoplasma pneumoniae characters (A2063G mutation or not, pathogen concentration) were not associated with the severity of MPP (P > 0.05). Furthermore, co-existing pathogens analysis showed that the SMPP group had a lower number of co-detected pathogens, children with human respiratory syncytial virus (RSV) co-existing were more frequent in the SMPP group (all P < 0.05). Multivariate analysis showed that lower number of co-detected pathogens (decreased microbial diversity), RSV co-existing, elevated CRP, and LDH were independent risk factors for SMPP.
conclusionCollectively, our data showed that respiratory microbiome and host response may play important roles in the pathology of MPP, decreased microbial diversity, RSV co-existing, CRP, and LDH level can predict the severity of MPP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.